| Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics L Pastorelli, C De Salvo, JR Mercado, M Vecchi, TT Pizarro Frontiers in immunology 4, 280, 2013 | 490 | 2013 |
| Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis L Pastorelli, RR Garg, SB Hoang, L Spina, B Mattioli, M Scarpa, C Fiocchi, ... Proceedings of the National Academy of Sciences 107 (17), 8017-8022, 2010 | 480 | 2010 |
| Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study C Bezzio, S Saibeni, A Variola, M Allocca, A Massari, V Gerardi, V Casini, ... Gut 69 (7), 1213-1217, 2020 | 345 | 2020 |
| Differential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectives GE Tontini, M Vecchi, L Pastorelli, MF Neurath, H Neumann World journal of gastroenterology: WJG 21 (1), 21, 2015 | 264 | 2015 |
| SAMP1/YitFc mouse strain: a spontaneous model of Crohn's disease-like ileitis TT Pizarro, L Pastorelli, G Bamias, RR Garg, BK Reuter, JR Mercado, ... Inflammatory bowel diseases 17 (12), 2566-2584, 2011 | 198 | 2011 |
| IL-33 activates tumor stroma to promote intestinal polyposis RL Maywald, SK Doerner, L Pastorelli, C De Salvo, SM Benton, ... Proceedings of the National Academy of Sciences 112 (19), E2487-E2496, 2015 | 177 | 2015 |
| Probiotic bacteria regulate intestinal epithelial permeability in experimental ileitis by a TNF-dependent mechanism D Corridoni, L Pastorelli, B Mattioli, S Locovei, D Ishikawa, KO Arseneau, ... PloS one 7 (7), e42067, 2012 | 129 | 2012 |
| Associations between genetic polymorphisms in IL-33, IL1R1 and risk for inflammatory bowel disease A Latiano, O Palmieri, L Pastorelli, M Vecchi, TT Pizarro, F Bossa, G Merla, ... PloS one 8 (4), e62144, 2013 | 114 | 2013 |
| IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair LR Lopetuso, C De Salvo, L Pastorelli, N Rana, HN Senkfor, V Petito, ... Proceedings of the National Academy of Sciences 115 (40), E9362-E9370, 2018 | 99 | 2018 |
| Neurological disorders and inflammatory bowel diseases G Casella, GE Tontini, G Bassotti, L Pastorelli, V Villanacci, L Spina, ... World Journal of Gastroenterology: WJG 20 (27), 8764, 2014 | 90 | 2014 |
| The role of IL-33 in gut mucosal inflammation L Pastorelli, C De Salvo, M Vecchi, TT Pizarro Mediators of inflammation 2013, 2013 | 82 | 2013 |
| Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised … L Peyrin-Biroulet, A Hart, P Bossuyt, M Long, M Allez, P Juillerat, ... The lancet Gastroenterology & hepatology 7 (2), 128-140, 2022 | 79 | 2022 |
| A consumer’s guide for probiotics: 10 golden rules for a correct use M Toscano, R De Grandi, L Pastorelli, M Vecchi, L Drago Digestive and Liver Disease 49 (11), 1177-1184, 2017 | 74 | 2017 |
| Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study S Danese, JF Colombel, M Lukas, JP Gisbert, G d'Haens, B Hayee, ... The lancet Gastroenterology & hepatology 7 (2), 118-127, 2022 | 68 | 2022 |
| Smoking is associated with extra-intestinal manifestations in inflammatory bowel disease M Severs, SJH van Erp, ME Van Der Valk, MJJ Mangen, HH Fidder, ... Journal of Crohn's and Colitis 10 (4), 455-461, 2016 | 66 | 2016 |
| IL-33 drives eosinophil infiltration and pathogenic type 2 helper T-cell immune responses leading to chronic experimental ileitis C De Salvo, XM Wang, L Pastorelli, B Mattioli, S Omenetti, KA Buela, ... The American Journal of Pathology 186 (4), 885-898, 2016 | 65 | 2016 |
| Microscopic colitis: what do we know about pathogenesis? LF Pisani, GE Tontini, M Vecchi, L Pastorelli Inflammatory bowel diseases 22 (2), 450-458, 2016 | 63 | 2016 |
| PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical … X Gui, A Bazarova, R Del Amor, M Vieth, G De Hertogh, V Villanacci, ... Gut 71 (5), 889-898, 2022 | 62 | 2022 |
| Novel cytokine signaling pathways in inflammatory bowel disease: insight into the dichotomous functions of IL-33 during chronic intestinal inflammation L Pastorelli, C De Salvo, MA Cominelli, M Vecchi, TT Pizarro Therapeutic advances in gastroenterology 4 (5), 311-323, 2011 | 61 | 2011 |
| Challenges in the care of IBD patients during the CoViD-19 pandemic: report from a “Red Zone” area in Northern Italy V Occhipinti, L Pastorelli Inflammatory bowel diseases 26 (6), 793-796, 2020 | 59 | 2020 |
